Skip to main content
Clinical Trials/NL-OMON54736
NL-OMON54736
Completed
Not Applicable

Single-cell analysis of somatic mutations to understand and improve blood formation after hematopoietic stem cell transplantation - Tracing stem cells after transplantation

Prinses Máxima Centrum voor Kinderoncologie0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Prinses Máxima Centrum voor Kinderoncologie
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Prinses Máxima Centrum voor Kinderoncologie

Eligibility Criteria

Inclusion Criteria

  • Patients (n\=30\):
  • \- Recipients of an allogeneic hematopoietic stem cell transplantation (HSCT)
  • from an umbilical cord blood donor (n\=10\), adult haplo donor (n\=10\), or healthy
  • sibling donor (n\=10\)
  • \- Age at HSCT \<18 yrs
  • \- First HSCT
  • \- \>95% donor chimerism at the time of blood sampling
  • \- Currently alive
  • \- No major HSCT\-related complications (see exclusion criteria),
  • Healthy subjects (n\=20\):

Exclusion Criteria

  • \- Major HSCT\-related complications, such as \>grade 2 graft versus host disease.
  • \- Secondary graft failure
  • \- Objection to be notified about actionable findings from whole\-genome
  • sequencing.
  • \- Failure of the HSCT recipient, donor and/or their legal representatives to
  • understand the patient information and informed consent form (either due to
  • intellectual disability or to language problems). Of note: For sibling and
  • haplo transplants, we will only include subjects in whom both the HSCT
  • recipient and his/her donor (and, if applicable, their caregivers) agree to
  • participate in the current study.

Outcomes

Primary Outcomes

Not specified

Similar Trials